ACB

Aurora Cannabis Inc.

$3.46

-0.10 (-2.81%)

Mkt Cap 196.21M

Volume 422,103

52W Range 3.07-6.665

Sector Healthcare

Beta 1.33

EPS (TTM) -1.69

P/E Ratio 217.84

Revenue (TTM) 363.29M

Rev Growth (5Y) +6.0%

EPS Growth (5Y) +7.7%

AlphaVal · Fair Value

$1.30

Overvalued · Strong

165.3% above fair value

Company Description

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Track Record

Showing latest 4 periods • Swipe for more

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	343.29M	270.28M	223.80M	221.34M	245.25M	268.70M	245.54M	55.20M	18.07M	1.44M	0	0
Net Income	1.59M	(69.33M)	(816.63M)	(1.72B)	(693.62M)	(3.28B)	(293.51M)	71.94M	(12.97M)	(5.72M)	(9.52M)	(399,705)
EPS	0.03	-1.28	-8.17	-79.92	-40.92	-333.92	-36.65	18.77	-5.58	-5.32	-9.87	-16.26
Free Cash Flow	(2.85M)	(85.34M)	(127.95M)	(142.48M)	(263.66M)	(690.96M)	(606.43M)	(218.61M)	(39.10M)	(8.66M)	N/A	N/A
FCF / Share	-0.05	-1.66	-3.96	-6.63	-15.55	-70.29	-75.73	-54.70	-18.09	-8.05	N/A	N/A
Operating CF	16.00M	(68.51M)	(115.82M)	(110.27M)	(210.58M)	(342.14M)	(192.25M)	(81.67M)	(13.38M)	(6.77M)	N/A	N/A
Total Assets	847.77M	840.14M	926.38M	926.38M	2.72B	2.92B	5.64B	1.90B	323.82M	18.32M	N/A	N/A
Total Debt	103.98M	99.78M	226.41M	226.41M	399.05M	529.01M	647.29M	204.60M	64.11M	10.64M	N/A	N/A
Cash & Equiv	184.26M	179.53M	300.86M	300.86M	440.30M	161.49M	219.63M	90.80M	160.28M	257,975	N/A	N/A
Book Value	563.91M	560.75M	490.67M	490.67M	2.04B	2.14B	4.40B	1.56B	219.71M	5.74M	N/A	N/A
Return on Equity	0.00	-0.12	-1.66	-3.50	-0.34	-1.54	-0.07	0.05	-0.06	-1.00	N/A	N/A

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023
Revenue	94.19M	90.37M	88.20M	90.54M	88.20M	81.12M	83.44M	67.41M	64.38M	63.12M	74.73M	71.31M
Net Income	1.82M	(51.47M)	31.67M	(24.56M)	31.67M	(12.04M)	6.52M	(17.41M)	(17.04M)	(523,000)	(26.90M)	472.03M
EPS	0.03	-0.91	-0.36	-0.45	0.58	-0.22	0.13	-0.26	-0.52	-0.01	-0.83	13.63
Free Cash Flow	11.02M	(46.75M)	5.08M	(623,000)	23.98M	(29.43M)	3.22M	(26.81M)	(8.04M)	(35.07M)	(15.53M)	(27.60M)
FCF / Share	0.19	-0.85	0.09	-0.01	0.44	-0.54	0.06	-0.52	-0.17	-0.91	-0.44	-0.80
Operating CF	17.00M	(40.40M)	10.12M	3.68M	28.84M	(24.89M)	8.38M	(21.13M)	(5.26M)	(30.88M)	(11.24M)	(24.04M)
Total Assets	775.29M	756.86M	841.94M	847.77M	865.94M	807.45M	838.12M	840.14M	817.24M	815.79M	831.69M	926.38M
Total Debt	101.00M	100.34M	102.13M	103.98M	100.91M	100.81M	102.04M	104.97M	103.35M	126.61M	156.29M	227.54M
Cash & Equiv	56.36M	95.69M	186.94M	184.26M	180.06M	151.35M	182.04M	179.53M	205.01M	192.21M	223.38M	300.86M
Book Value	536.36M	531.91M	554.62M	563.91M	572.53M	542.29M	561.24M	560.75M	516.49M	502.19M	475.45M	490.67M
Return on Equity	0.00	-0.10	0.06	-0.04	0.06	-0.02	0.01	-0.03	-0.03	-0.00	-0.06	0.96